This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Karuna Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Niall Wagstaff: Innovator in Pharmaceutical Compounds
Introduction
Niall Wagstaff is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address medical conditions.
Latest Patents
Wagstaff holds a patent for "Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditions." This invention provides substituted tetrahydropyrrolo-pyridinone compounds, pharmaceutical compositions, and their application in treating muscarinic acetylcholine receptor mediated disorders. His innovative work has the potential to impact various therapeutic areas.
Career Highlights
Niall Wagstaff is associated with Karuna Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in pharmaceutical compounds has positioned him as a valuable asset in the industry.
Collaborations
Wagstaff has collaborated with notable colleagues, including Kevin Matthew Gardinier and James Edmund Audia. These partnerships enhance the collaborative spirit of innovation within the pharmaceutical sector.
Conclusion
Niall Wagstaff's contributions to the field of pharmaceuticals through his patented inventions demonstrate his commitment to advancing medical science. His work continues to inspire innovation in treating complex medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile